TIPRL and lung carcinoma: To determine whether TIPRL involved in stemness and anticancer drug resistance as a target for eliminating lung CSCs, we examined its expression in lung cancer tissues, including lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and small cell lung cancer (SCLC).